Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.07
17.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
|
9.4B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.2B USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
526.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
276.2B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.7B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.7B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.8B USD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Zhejiang Garden Bio-chemical High-tech Co Ltd
Glance View
Zhejiang Garden Bio-chemical High-tech Co Ltd, nestled in the economic heart of China, boasts a robust presence in the global vitamin industry. Established with a keen focus on biosynthesis, the company has carved a niche for itself by specializing in the production of Vitamin D3. As a key player in the vitamin sector, Garden Bio-chemical uses advanced biotechnological methods to convert raw materials such as lanolin, derived from sheep's wool, into highly purified Vitamin D3. This complex process involves carefully monitored steps of extraction and fermentation, ensuring the production of high-quality vitamins that meet stringent international standards. The company’s financial health is intricately tied to its ability to meet the rising demand for vitamins across diverse markets, particularly in health-conscious segments. With the growing global emphasis on nutrition and wellness, Garden Bio-chemical capitalizes on this trend by enhancing its production capabilities and expanding its market reach. The company's revenue model relies heavily on large-scale contracts with pharmaceutical companies, dietary supplement manufacturers, and other sectors that require consistent and reliable supplies of Vitamin D3. By maintaining strong relationships with its clients and continuing to innovate in its production processes, Zhejiang Garden Bio-chemical High-tech Co Ltd ensures sustainability and profitability in an increasingly competitive market.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Zhejiang Garden Bio-chemical High-tech Co Ltd is 29.2%, which is above its 3-year median of 24.6%.
Over the last 3 years, Zhejiang Garden Bio-chemical High-tech Co Ltd’s Operating Margin has decreased from 34.9% to 29.2%. During this period, it reached a low of 16.8% on Sep 30, 2023 and a high of 34.9% on Aug 30, 2022.